JAK2 and triple-negative breast carcinoma: However, contrasting reports have shown that Siglec-1+ macrophages mediate immunosuppression via JAK2/STAT3 signaling in triple-negative breast cancer cells [16], suggesting that Siglec-1 plays complicated roles in different TMEs.